Journal of Clinical Gynecology and Obstetrics, ISSN 1927-1271 print, 1927-128X online, Open Access
Article copyright, the authors; Journal compilation copyright, J Clin Gynecol Obstet and Elmer Press Inc
Journal website https://jcgo.elmerpub.com

Review

Volume 000, Number 000, November 2026, pages 000-000


The Endometrial–Vaginal Microbiota Axis as a Determinant of Implantation and Live Birth Outcomes in Assisted Reproductive Technology

Figures

↓  Figure 1. The endometrial–vaginal microbiota axis as a determinant of implantation success in ART. Source: original schematic created by the authors, synthesizing the immune-mechanistic evidence summarized in References [6, 20, 22, 27]. ART: assisted reproductive technology.
Figure 1.
↓  Figure 2. Clinical pathway decision tree: proposal for a personalized, microbiome-guided clinical pathway in ART. Source: original schematic proposed by the authors, adapting the microbiome-guided pathway concepts and intervention evidence summarized in References [35, 37–39, 51, 53]. Diagrammatic proposal for a future evidence-based ART pathway, whereby universal or targeted microbiota screening (vagina, cervix, endometrium) is integrated into personalized risk stratification. This model suggests that the detection of an unfavorable (NLD) microbiome signature should trigger the delay of embryo transfer in favor of targeted antibiotic and probiotic intervention loops to optimize endometrial receptivity before transfer. ART: assisted reproductive technology; CE: chronic endometritis; CST: community state type; LD: Lactobacillus-dominant; NLD: non-Lactobacillus-dominant; RIF: recurrent implantation failure; RPL: recurrent pregnancy loss.
Figure 2.

Tables

↓  Table 1. Vaginal CSTs and Pathophysiological Profiles [6, 12–15]
 
CSTDominant speciesMetabolic & biochemical profileImmunological stateImpact on ART outcomes
ART: assisted reproductive technology; CSTs: community state types; IL-6: interleukin-6; RIF: recurrent implantation failure; TNF-α: tumor necrosis factor-alpha.
CST ILactobacillus crispatusHigh lactic acid production, significant hydrogen peroxide (H2O2) and bacteriocin synthesis; maintains strict acidic pH (∼4.0).Highly tolerogenic mucosal environment; suppresses pro-inflammatory cytokines; robust barrier integrity.Highly favorable: Strongly associated with the highest implantation, clinical pregnancy, and live birth rates.
CST IILactobacillus gasseriModerate lactic acid and H2O2 production; stable acidic pH maintenance.Tolerogenic; limits opportunistic pathogen adherence and epithelial invasion.Favorable: Supports healthy embryo-maternal dialogue and successful implantation, though slightly less robust than CST I.
CST IIILactobacillus inersVariable lactic acid production; often lacks H2O2 synthesis; prone to pH fluctuations.Transitional state; can shift toward inflammation under stress or hormonal shifts.Intermediate/vulnerable: Often observed in transitional states prior to dysbiosis; associated with less predictable ART outcomes.
CST VLactobacillus jenseniiEffective lactic acid production; provides consistent competitive exclusion against pathogens.Tolerogenic; supports stable mucosal immunity.Favorable: Comparable to CST II; supports optimal endometrial receptivity and ongoing pregnancy.
CST IVPolymicrobial dysbiosis (e.g., Gardnerella, Atopobium, Prevotella, Sneathia)Elevated pH (> 4.5); reduced lactic acid; increased production of volatile amines and local endotoxins.Pro-inflammatory; disruption of epithelial tight junctions; recruitment of Th1/Th17 cells; elevated IL-6 and TNF-α.Highly unfavorable: Directly linked to RIF, biochemical pregnancy, and early pregnancy loss.

 

↓  Table 2. Proposed Mechanisms Linking the Genital Microbiota Axis to ART Outcomes [4, 6, 20, 22, 25–28]
 
Microbiota profilePrimary commensals/pathogensImmunological & cellular impactImpact on endometrial receptivity & ART
ART: assisted reproductive technology; IFN-γ: interferon-gamma; IL-6: interleukin-6; IL-17: interleukin-17; LIF: leukemia inhibitory factor; TNF-α: tumor necrosis factor-alpha.
Eubiotic (Lactobacillus-dominant)L. crispatus, L. iners, L. jenseniiMaintains low pH via lactic acid; produces H2O2 and bacteriocins. Promotes tolerogenic mucosal environment and Treg expansion.Supports embryo tolerance and optimal expression of receptivity markers; associated with higher live birth rates.
Dysbiotic (non-Lactobacillus)Gardnerella, Atopobium, Prevotella, StreptococcusInduces pro-inflammatory cytokines (IFN-γ, TNF-α, IL-6, IL-17); alters Th1/Th17 balance. Promotes biofilm formation.Down-regulates receptivity genes (LIF, integrin ανβ3, HOXA10); disrupts epithelial barriers, leading to implantation failure or loss.

 

↓  Table 3. Proposed Microbiome-Based Biomarkers for Personalized ART Prediction [32, 35–39]
 
Biomarker concept/signatureDiagnostic nichePrimary diagnostic signalProposed clinical application in ARTPredictive accuracy & utility
ART: assisted reproductive technology; CST: community state type; LDM: Lactobacillus-dominant microbiota; NLDM: non-Lactobacillus-dominant microbiota; WGS: whole-genome sequencing.
Endometrial LDM vs. NLDMEndometrial fluid or biopsy (pre-transfer)Eubiosis is defined as ≥ 90% Lactobacillus spp. (LDM). Dysbiosis (NLDM) is < 90% with > 10% pathogenic/opportunistic taxa.Identification of hostile uterine microenvironments prior to embryo transfer; guides the use of targeted antibiotics for chronic endometritis.Strong correlation with live birth probability; NLDM strongly predicts severe implantation failure and subsequent miscarriage.
Vaginal CST profilingVaginal swab (follicular phase or pre-stimulation)Identification of CST I (optimal) versus CST IV (dysbiotic).Non-invasive pre-cycle screening to stratify patients into high-chance versus low-chance prognostic categories.High negative predictive value; effectively identifies patients at high risk of cycle failure due to ascending dysbiosis.
Multi-taxa predictive algorithms (e.g., “ReceptIVFity”)Vaginal or cervical swabWeighted ratio of favorable (L. crispatus) versus unfavorable (Gardnerella, Atopobium, L. iners) taxa.Algorithmic risk stratification directing the decision to proceed with fresh embryo transfer or freeze-all and treat.Validated models demonstrate up to a 94% negative predictive value for implantation failure in designated “low chance” groups.
Functional pathway biomarkers (metagenomic)Genital tract fluid (WGS)Presence of specific bacterial metabolic pathways (e.g., localized lipopolysaccharide synthesis vs. short-chain fatty acids).Experimental; aims to move beyond taxonomy to measure the actual biochemical hostility of the reproductive tract.Early-stage data; promises high precision by directly measuring the metabolic drivers of local mucosal inflammation.

 

↓  Table 4. Current and Emerging Therapeutic Modulations of the Genital Microbiome [35, 37, 40–45]
 
Therapeutic strategyTarget/mechanism of actionCurrent evidence in ARTKey limitations & risks
ART: assisted reproductive technology; BV: bacterial vaginosis; CE: chronic endometritis; LD: Lactobacillus-dominant; NLD: non-Lactobacillus-dominant; VMT: vaginal microbiome transplantation.
AntibioticsBroad-spectrum clearance of CE or BV.Standard of care for CE; observational data shows improved implantation after histological resolution.High recurrence rates for BV; risks microbiome disruption, collateral damage to Lactobacillus, and antimicrobial resistance.
Probiotics (oral/vaginal)Shift communities toward Lactobacillus-dominance; restore acidic pH and suppress pathogens.Moderate modulation shown; some case series report conversion from NLD to LD endometria.High protocol heterogeneity; barrier of colonization resistance; inconsistent clinical pregnancy gains.
VMTTransfer of vaginal fluid from healthy donor to resolve refractory dysbiosis.Promising symptom resolution in small, non-ART BV series where antibiotics failed.Experimental; requires stringent donor screening and long-term safety monitoring before ART application.

 

↓  Table 5. Representative Studies Illustrating Sampling and Technological Heterogeneity [4, 8, 15, 21, 32, 36, 38, 39]
 
StudySample typeTechnologyPrimary outcome(s)Key limitations
ART: assisted reproductive technology; LDM: Lactobacillus-dominant microbiota; NLDM: non-Lactobacillus-dominant microbiota; qPCR: quantitative polymerase chain reaction; WGS: whole-genome sequencing.
Moreno et al, 2016 [21]Endometrial fluid aspirate16S rRNA sequencingLDM vs. NLDM: implantation 60.7% vs. 23.1%; live birth 58.8% vs. 6.7%Small, single-center cohort; receptive-endometrium subgroup only
Moreno et al, 2021 [4]Endometrial biopsy16S rRNA sequencing, multicenterLactobacillus enrichment associated with pregnancy; dysbiotic taxa predicted no pregnancy/miscarriageObservational design; single pre-transfer sampling; causality not established
Koedooder et al (“ReceptIVFity”) [38, 39]Vaginal swab16S rRNA + qPCR panel94% negative predictive value for implantation failure in “low-chance” profilePredictive algorithm not yet externally validated in independent cohorts
Villani et al, 2022 [32]Cervical swab16S rRNA (PELORA regression)L. crispatus/salivarius/rhamnosus enrichment discriminated women who conceivedCervical sampling may not reflect endometrial community
Polifke et al, 2024 [15]Paired vaginal + endometrial biopsy16S rRNA sequencingEndometrial and vaginal profiles differ; endometrium more diverseLow endometrial biomass; high contamination risk
Chen et al, 2017 [8]Vaginal, cervical, upper-tract (multi-site)16S rRNA sequencingDemonstrated microbial continuum along the reproductive tractNot ART-outcome focused; cross-sectional
Behrendt-Møller et al, 2025 [36]Vaginal and rectal samplesShotgun metagenomics (WGS), ≥ 30 million reads/sampleTaxa linked to pregnancy and live birth outcomesConference abstract with limited methodological and outcome detail